NOV 15, 2017 9:00 AM PST

WEBINAR: The essential role of miRNA and mRNA on cancer progression and biomarker discovery

Speaker
  • Head of Basic Research, Clinic for Gastroenterology, University of Marburg
    Biography
      Malte Buchholz obtained his PhD in molecular biology at the University of Goettingen, Germany, in 1998. He is group leader and Head of Basic Research at the Department of Gastroenterology, Endocrinology and Metabolism, University Hospital Marburg, Philipps-University of Marburg, Germany (http://www.uni-marburg.de/fb20/gastroendokrinol/forschung?language_sync=1). His research interests focus on transcriptome analyses and molecular diagnostics of gastrointestinal tumors, functional genomic analyses of pancreatic cancer, and molecular determinants of tumor-host interactions. Among others, he has performed global gene expression analyses of stromal cell populations from different organs as well as microdissected tumor cells and pre-neoplastic lesions from pancreatic ductal adenocarcinoma (PDAC) patients. These data formed an important basis for the design of specialized cDNA arrays which are suitable to distinguish between different forms of pancreatico-biliary tumors with high diagnostic precision. In addition, his group has identified and characterized novel candidate genes with central roles in the physiology of pancreatic tumor cells.
      Dr. Buchholz has been intimately involved in the management and coordination of several national and international multidisciplinary research projects, including the BMBF-funded NGFNplus project "PaCa-Net" as well as the EU FP7 collaborative projects "MolDiag-PaCa" and "European Pancreatic Cancer-Tumor-Microenvironment Network (EPC-TM-Net)". He is currently co-coordinator of the EU FP7 large-scale integrative project "CAM-PaC" (Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer)( http://www.cam-pac.eu/) and "Bio-PaC" (Biomarkers of tumor recurrence in pancreatic cancer), the latter of which focuses on the development of focused mixed TaqMan arrays as a diagnostic tool for the early detection of tumor recurrence in pancreatic cancer.

    Abstract

    DATE: November 15, 2017
    TIME: 09:00am PST, 12:00pm EST, 6:00pm CET

    MicroRNAs (miRNA) are a class of small non-coding RNAs (approximately 21 nt long) that bind complementary sequences in target mRNAs to specifically regulate gene expression. miRNAs play important roles in regulation of gene expression during cell development, differentiation, proliferation and apoptosis. Misregulation of miRNAs and their targets has been associated with several diseases including cancer. The interplay between miRNA and mRNA has been found to be important in cancer development and progression. Simultaneous expression studies of miRNA and mRNA can be valuable in understanding molecular mechanisms that may potentially have an underlying role in various diseases. In this webinar, we demonstrate the technical verification of a novel method to reverse transcribe and pre-amplify miRNA and mRNA from sample limiting serum research samples using TaqMan® Advanced miRNA cDNA synthesis Kit.

    Based on results from previous studies and unpublished data, Dr. Buchholz’s research group identified a signature of 49 mRNA and 37 miRNA targets that may help to distinguish between benign and malignant pancreatic tissues in the future. In this study these previously identified miRNA and mRNA targets have been used to study expression pattern differences in serum from Normal and Test samples. These miRNA and mRNA targets were spotted on Custom TaqMan array cards to facilitate investigation of 4 samples on each card. Initial results indicate that miRNA and mRNAs can be reliably quantified from a single reverse transcription reaction.

    Learning Objectives:

    • Study of miRNAs in Oncology Gene Expression
    • Understanding the interplay between miRNA and mRNA impacts cancer development and progression
    • Use of Data Analysis tools for Gene Expression studies involving miRNA and mRNA
    • Understanding molecular mechanisms that may potentially have an underlying role in various diseases

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 21, 2021 5:00 PM CEST
    APR 21, 2021 5:00 PM CEST
    Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 15, 2017 9:00 AM PST

    WEBINAR: The essential role of miRNA and mRNA on cancer progression and biomarker discovery


    Specialty

    Cancer Research

    Molecular Biology

    Cell Biology

    Biomarkers

    Biotechnology

    Molecular Diagnostics

    Cancer Diagnostics

    Genetics

    Immunology

    Cancer Therapeutics

    Oncology

    Clinical Diagnostics

    Biochemistry

    Clinical Research

    Gene Expression

    Geography

    North America54%

    Europe24%

    Asia12%

    South America4%

    Africa3%

    Oceania1%

    Registration Source

    Website Visitors99%

    Job Title

    Research Scientist17%

    Student16%

    Scientist12%

    Educator/Faculty10%

    Executive9%

    Medical Laboratory Technician7%

    Clinical Laboratory Scientist6%

    Medical Doctor/Specialist6%

    Post Doc5%

    Biologist3%

    Lab Management3%

    Facility/Department Manager3%

    Marketing/Sales2%

    Chemist1%

    Organization

    Academic Institution16%

    Clinical Laboratory8%

    Biotech Company7%

    Hospital5%

    Research Institute5%

    Medical School4%

    Government3%

    Pharmaceutical Company2%

    Ambulatory Care2%

    Life Science Company2%

    Consultant2%

    Contract Research Organization (Cro)1%

    Medical Center1%

    Medical Device Company1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more